Scientific American • 16th December 2020 Food Industry-Backed Research Gives Results Funders Want More than half of these studies yielded outcomes favorable to company products compared to less than 10 percent lacking such support
Scientific American • 3rd September 2020 How to Decide Who Should Get a COVID-19 Vaccine First Medical ethicist Ezekiel Emanuel discusses a framework for equitably allocating COVID-19 vaccines based on preventing premature deaths and mitigating long-term economic impacts
Scientific American • 24th September 2020 When and Why You Should Get a Flu Shot Experts explain why getting vaccinated is important every year—and especially during a pandemic
Scientific American • 20th July 2020 After Surgery, Black Children Are More Likely to Die Than White Children A study of nearly 200 U.S. medical centers found that even apparently healthy kids suffer racial disparities in complications associated with surgery
South Side Weekly • 24th June 2020 As the City Reopens, Mental Health Clinics Keep Services at a Distance A “significant portion” of services could stay remote as clinics permanently adopt telehealth
Scientific American • 7th May 2020 'Breakthrough' COVID-19 Tests Are Currently Cheap, Fast—and Not Very Accurate Antigen-based assays could be used in the home, but critics say their error rates are still an issue
Scientific American • 23rd April 2020 CRISPR Gene Editing May Help Scale Up Coronavirus Testing An inexpensive assay based on the technique can provide yes or no answers in under an hour
Scientific American • 27th March 2020 Here's How Coronavirus Tests Work—and Who Offers Them PCR-based tests are being rolled out in hospitals nationwide, and the Food and Drug Administration is fast-tracking novel approaches as well
Scientific American • 20th March 2020 How to Triage Patients Who Need Intensive Care A new computer model analyzes when to admit people to intensive care units—and when to move them out—which could help doctors handle the coronavirus surge
South Side Weekly • 4th February 2020 What Happened to the Mental Health Task Force? Public Health Commissioner Allison Arwady has proposed a new task force to “coordinate” mental health efforts
Scientific American • 20th January 2020 Old Drug, New Tricks: Existing Medicines Show Promise in Fighting Cancer Dozens of compounds approved for other purposes can kill cancer cells selectively
Nature • 4th December 2019 Gene Therapy Arrives After false starts, drugs that manipulate the code of life are finally changing lives.
Scientific American • 30th October 2019 Trump's Nativist Rhetoric Scares Immigrants Away from Seeking Medical Care A quarter of surveyed Latino patients said they knew someone who did not go to the hospital because of fear of deportation
Scientific American • 26th July 2019 Detained Migrant Children Need Continuous Medical Care Health care providers say a lack of transparency and communication are barriers to ensuring the children are getting adequate, ongoing treatment
Scientific American • 26th April 2019 Is the EPA Stifling Science on Chemical Toxicity Reports? Critics say changes to the agency’s review process will harm public health
Scientific American • 12th March 2019 Infectious Diseases Spike amid Venezuela's Political Turmoil Scientists say the rise in illnesses is due to a combination of government suppression of research, a lack of disease data and climate change
The Scientist Magazine® • 1st May 2018 Understanding What Makes a Successful Crowdfunding Campaign Researchers at the Rare Genomics Institute look at how families finance the cost of diagnostic exome sequencing.
Cancer Therapy Advisor • 27th May 2016 High Rate of Hepatocellular Carcinoma Recurrence Found in Patients With Hepatitis C Treated With Direct-acting Antiviral Agents
Cancer Therapy Advisor • 12th July 2016 Numerous Factors Contribute to Gender-based Disparity of Bladder Cancer Survival Access to chemotherapy is just one of many factors influencing disparities of bladder cancer survival rates.
Cancer Therapy Advisor • 29th March 2016 Oversized Single-dose Vials of Cancer Drugs Results in Billions of Wasted US Dollars
